EUROPEAN JOURNAL OF MEDICAL RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1099201, encodeId=236b10992013b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156171, encodeId=cb7621561e124, content=peer review已经5个月了，真闹心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed405505989, createdName=魏至瑶, createdTime=Tue Sep 05 10:36:32 CST 2023, time=2023-09-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123256, encodeId=5b472123256f2, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：辣鸡,4个月还在找编辑，编辑去哪了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caef8422644, createdName=ms4000002038428258, createdTime=Sun Apr 02 10:17:44 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093829, encodeId=c8c120938295a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：一直在分配编辑，分配了15个月...然后撤回来了，实在没编辑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48bf5074563, createdName=1459db01m00暂无昵称, createdTime=Fri Oct 14 20:23:58 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099202, encodeId=7fab1099202e0, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588428, encodeId=f14958842876, content=太慢太慢慢的出奇3月一点动静没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3141728645, createdName=fyqs01, createdTime=Wed Apr 08 15:12:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省)]

2021-12-29 rayms

摘要一定要描述使用的方法么？

67 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1099201, encodeId=236b10992013b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156171, encodeId=cb7621561e124, content=peer review已经5个月了，真闹心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed405505989, createdName=魏至瑶, createdTime=Tue Sep 05 10:36:32 CST 2023, time=2023-09-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123256, encodeId=5b472123256f2, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：辣鸡,4个月还在找编辑，编辑去哪了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caef8422644, createdName=ms4000002038428258, createdTime=Sun Apr 02 10:17:44 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093829, encodeId=c8c120938295a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：一直在分配编辑，分配了15个月...然后撤回来了，实在没编辑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48bf5074563, createdName=1459db01m00暂无昵称, createdTime=Fri Oct 14 20:23:58 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099202, encodeId=7fab1099202e0, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588428, encodeId=f14958842876, content=太慢太慢慢的出奇3月一点动静没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3141728645, createdName=fyqs01, createdTime=Wed Apr 08 15:12:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省)]

2024-02-25 逗你分分钟钟来自北京

生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。

16 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1099201, encodeId=236b10992013b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156171, encodeId=cb7621561e124, content=peer review已经5个月了，真闹心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed405505989, createdName=魏至瑶, createdTime=Tue Sep 05 10:36:32 CST 2023, time=2023-09-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123256, encodeId=5b472123256f2, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：辣鸡,4个月还在找编辑，编辑去哪了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caef8422644, createdName=ms4000002038428258, createdTime=Sun Apr 02 10:17:44 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093829, encodeId=c8c120938295a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：一直在分配编辑，分配了15个月...然后撤回来了，实在没编辑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48bf5074563, createdName=1459db01m00暂无昵称, createdTime=Fri Oct 14 20:23:58 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099202, encodeId=7fab1099202e0, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588428, encodeId=f14958842876, content=太慢太慢慢的出奇3月一点动静没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3141728645, createdName=fyqs01, createdTime=Wed Apr 08 15:12:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省)]

2024-02-27 无名者1123 来自湖北省

审稿速度:24.0 | 投稿命中率:25.0
经验分享：Editor assigned
On 03 Nov, 2023
Submission checks complete
On 02 Nov, 2023
First submitted to European Journal of Medical Research
On 01 Nov, 2023
请问这个状态已经持续三个多月了，是还没找到编辑吗

19 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1099201, encodeId=236b10992013b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156171, encodeId=cb7621561e124, content=peer review已经5个月了，真闹心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed405505989, createdName=魏至瑶, createdTime=Tue Sep 05 10:36:32 CST 2023, time=2023-09-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123256, encodeId=5b472123256f2, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：辣鸡,4个月还在找编辑，编辑去哪了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caef8422644, createdName=ms4000002038428258, createdTime=Sun Apr 02 10:17:44 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093829, encodeId=c8c120938295a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：一直在分配编辑，分配了15个月...然后撤回来了，实在没编辑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48bf5074563, createdName=1459db01m00暂无昵称, createdTime=Fri Oct 14 20:23:58 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099202, encodeId=7fab1099202e0, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588428, encodeId=f14958842876, content=太慢太慢慢的出奇3月一点动静没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3141728645, createdName=fyqs01, createdTime=Wed Apr 08 15:12:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省)]

2023-09-05 魏至瑶来自北京

peer review已经5个月了，真闹心

38 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1099201, encodeId=236b10992013b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156171, encodeId=cb7621561e124, content=peer review已经5个月了，真闹心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed405505989, createdName=魏至瑶, createdTime=Tue Sep 05 10:36:32 CST 2023, time=2023-09-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123256, encodeId=5b472123256f2, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：辣鸡,4个月还在找编辑，编辑去哪了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caef8422644, createdName=ms4000002038428258, createdTime=Sun Apr 02 10:17:44 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093829, encodeId=c8c120938295a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：一直在分配编辑，分配了15个月...然后撤回来了，实在没编辑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48bf5074563, createdName=1459db01m00暂无昵称, createdTime=Fri Oct 14 20:23:58 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099202, encodeId=7fab1099202e0, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588428, encodeId=f14958842876, content=太慢太慢慢的出奇3月一点动静没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3141728645, createdName=fyqs01, createdTime=Wed Apr 08 15:12:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省)]

2023-04-02 ms4000002038428258 来自北京

审稿速度:6.0 | 投稿命中率:5.0
经验分享：辣鸡,4个月还在找编辑，编辑去哪了？

40 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1099201, encodeId=236b10992013b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156171, encodeId=cb7621561e124, content=peer review已经5个月了，真闹心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed405505989, createdName=魏至瑶, createdTime=Tue Sep 05 10:36:32 CST 2023, time=2023-09-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123256, encodeId=5b472123256f2, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：辣鸡,4个月还在找编辑，编辑去哪了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caef8422644, createdName=ms4000002038428258, createdTime=Sun Apr 02 10:17:44 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093829, encodeId=c8c120938295a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：一直在分配编辑，分配了15个月...然后撤回来了，实在没编辑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48bf5074563, createdName=1459db01m00暂无昵称, createdTime=Fri Oct 14 20:23:58 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099202, encodeId=7fab1099202e0, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588428, encodeId=f14958842876, content=太慢太慢慢的出奇3月一点动静没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3141728645, createdName=fyqs01, createdTime=Wed Apr 08 15:12:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省)]

2022-10-14 1459db01m00暂无昵称

审稿速度:24.0 | 投稿命中率:5.0
偏重的研究方向：骨科
经验分享：一直在分配编辑，分配了15个月...然后撤回来了，实在没编辑...

63 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1099201, encodeId=236b10992013b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156171, encodeId=cb7621561e124, content=peer review已经5个月了，真闹心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed405505989, createdName=魏至瑶, createdTime=Tue Sep 05 10:36:32 CST 2023, time=2023-09-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123256, encodeId=5b472123256f2, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：辣鸡,4个月还在找编辑，编辑去哪了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caef8422644, createdName=ms4000002038428258, createdTime=Sun Apr 02 10:17:44 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093829, encodeId=c8c120938295a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：一直在分配编辑，分配了15个月...然后撤回来了，实在没编辑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48bf5074563, createdName=1459db01m00暂无昵称, createdTime=Fri Oct 14 20:23:58 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099202, encodeId=7fab1099202e0, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588428, encodeId=f14958842876, content=太慢太慢慢的出奇3月一点动静没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3141728645, createdName=fyqs01, createdTime=Wed Apr 08 15:12:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省)]

2021-12-27 msSSSSSD

摘要中一定要加入研究目标么？

63 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1099201, encodeId=236b10992013b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156171, encodeId=cb7621561e124, content=peer review已经5个月了，真闹心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed405505989, createdName=魏至瑶, createdTime=Tue Sep 05 10:36:32 CST 2023, time=2023-09-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123256, encodeId=5b472123256f2, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：辣鸡,4个月还在找编辑，编辑去哪了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caef8422644, createdName=ms4000002038428258, createdTime=Sun Apr 02 10:17:44 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093829, encodeId=c8c120938295a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：一直在分配编辑，分配了15个月...然后撤回来了，实在没编辑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48bf5074563, createdName=1459db01m00暂无昵称, createdTime=Fri Oct 14 20:23:58 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099202, encodeId=7fab1099202e0, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588428, encodeId=f14958842876, content=太慢太慢慢的出奇3月一点动静没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3141728645, createdName=fyqs01, createdTime=Wed Apr 08 15:12:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省)]

2020-04-08 fyqs01

太慢太慢慢的出奇3月一点动静没有

160 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1099201, encodeId=236b10992013b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156171, encodeId=cb7621561e124, content=peer review已经5个月了，真闹心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed405505989, createdName=魏至瑶, createdTime=Tue Sep 05 10:36:32 CST 2023, time=2023-09-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123256, encodeId=5b472123256f2, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：辣鸡,4个月还在找编辑，编辑去哪了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caef8422644, createdName=ms4000002038428258, createdTime=Sun Apr 02 10:17:44 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093829, encodeId=c8c120938295a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：一直在分配编辑，分配了15个月...然后撤回来了，实在没编辑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48bf5074563, createdName=1459db01m00暂无昵称, createdTime=Fri Oct 14 20:23:58 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099202, encodeId=7fab1099202e0, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588428, encodeId=f14958842876, content=太慢太慢慢的出奇3月一点动静没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3141728645, createdName=fyqs01, createdTime=Wed Apr 08 15:12:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省)]

2024-02-22 ms6000000356171322 来自吉林省

审稿速度:6.0 | 投稿命中率:95.0
偏重的研究方向：糖尿病
经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date
Submission accepted
21 Feb 2024
Submission under peer review
10 Feb 2024
Submission passed technical check
10 Feb 2024
Amendment received
09 Feb 2024
Revision received
09 Feb 2024
Submission under peer review
05 Dec 2023
Technical check
Submission status Date
Submission passed technical check
05 Dec 2023
Amendment received
05 Dec 2023
Submission is under technical check
04 Dec 2023
Submission received
Submission status Date
Submission received
04 Dec 2023

36 0

[GetPortalCommentsPageByObjectIdResponse(id=1099201, encodeId=236b10992013b, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156171, encodeId=cb7621561e124, content=peer review已经5个月了，真闹心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed405505989, createdName=魏至瑶, createdTime=Tue Sep 05 10:36:32 CST 2023, time=2023-09-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123256, encodeId=5b472123256f2, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：辣鸡,4个月还在找编辑，编辑去哪了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caef8422644, createdName=ms4000002038428258, createdTime=Sun Apr 02 10:17:44 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093829, encodeId=c8c120938295a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：骨科 经验分享：一直在分配编辑，分配了15个月...然后撤回来了，实在没编辑..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48bf5074563, createdName=1459db01m00暂无昵称, createdTime=Fri Oct 14 20:23:58 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099202, encodeId=7fab1099202e0, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588428, encodeId=f14958842876, content=太慢太慢慢的出奇3月一点动静没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3141728645, createdName=fyqs01, createdTime=Wed Apr 08 15:12:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省)]

2024-01-12 ms9000000801374228 来自广东省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：临床
经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。

0 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务